Tuesday, December 07, 2021 7:48:54 AM
Press Release | 12/06/2021
IRVINE, CA December 6, 2021 - ORHub, Inc. (OTC: ORHB) ORHub today announces Sean McMenamins addition to the Board of Directors. Mr. McMenamin will help to provide board level oversight of the Companys leadership, potential acquisitions, and audits. I am grateful Mr. McMenamin accepted the invitation to join the Board, as he compliments the team with additional financial expertise. He is highly talented, capable, and a great fit, expressed CJ Wiggins, MBA - ORHub Founder, Executive Chairman, President, & CEO.
The opportunity ORHub has to improve financial transactions and business efficiency for hospitals and medical device manufacturers is impressive, stated Mr. McMenamin. The industry is in need of a solution and the financial impact will be a win for everyone.
Mr. McMenamin understands what we are doing, brings great vision, and offers an independent insight which is beneficial to us all. stated Melissa Moore, Corporate Secretary & VP of Operations.
--------------
Additional upcoming information:
For more on ORHub, visit: www.ORHub.com
Connect with ORHub on LinkedIn: linkedin.com/company/orhub Follow @ORHub on Twitter: twitter.com/orhub
About ORHub, Inc.
ORHub, Inc. (OTC: ORHB) is headquartered in Irvine, California. The company is focused on the Internet of Things (IoT), creating Intelligent Automation and connected mobility solutions to help revolutionize healthcare for a more sustainable and connected future. ORHubs solutions create intelligent data, activate new and improved methods of managing multi-vendor transaction details, and digitize payments, all of which improve the necessary and undervalued business relationship between hospital customers and supporting medical device and biotech vendors. These solutions are believed to form a valuable foundation for potential new uses of AI, future of quantum computing, and a mobile ecosystem for personalized implant and other patient centered information and accessibility.
###
Forward-looking Statements
This release contains forward-looking statements, including the market demand for and acceptance of ORHubs products and services, the results from use of ORHubs products and services, and general business conditions, particularly within the surgical, life science, and medical device industries. Any forward-looking statements contained in this press release are based upon ORHubs historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ORHubs expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ORHub disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Further information on potential risks that could affect actual results will be included in future filings made by ORHub and are available on the Companys website at ORHub.com from time to time.
Contact:
Jason Brown
ORHub, Inc.
612-209-7565
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM